Petros Pharmaceuticals, Inc. (PTPI) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US71678J1007
Price
0.00 USD
Market cap
127,116.78 USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–
Petros Pharmaceuticals, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -4.64 m USD |
| EBIT | 1.91 m USD |
| Net income | 1.91 m USD |
| Diluted EPS – continuing operations | -1.56 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
More stocks
- Hongchang International Co., Ltd (HCIL)
- Digital Brands Group, Inc. (DBGI)
- Sigyn Therapeutics, Inc. (SIGY)
- First Choice Healthcare Solutions, Inc. (FCHS)
- Data443 Risk Mitigation, Inc. (ATDS)
- MEDIGENE N (MDG1.SG) (MDG1.SG)
- Winvest Group Ltd (WNLV)
- Kuber Resources Corp (KUBR)
- APPlife Digital Solutions Inc (ALDS)
- Recon Technology, Ltd (RCON)
- Cenntro Inc. (CENN)
- CIRTRAN CORP (CIRX)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.